Cargando…
Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis
BACKGROUND: The Mtb72f subunit vaccine for tuberculosis, currently in clinical trials, is hoped to provide improved protection compared to the current BCG vaccine. It is not clear, however, whether Mtb72f would be equally protective in the different human populations suffering from a high burden of...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2862017/ https://www.ncbi.nlm.nih.gov/pubmed/20353587 http://dx.doi.org/10.1186/1471-2172-11-18 |